ID   UT14
AC   CVCL_VJ96
DR   CCRID; 1101HUM-PUMC000598
DR   Cosmic; 2653720
DR   GEO; GSM2375328
DR   GEO; GSM2375329
DR   GEO; GSM2375330
DR   GEO; GSM2386067
DR   GEO; GSM2386072
DR   GEO; GSM2386073
DR   Wikidata; Q98134379
RX   PubMed=28256713;
CC   Population: Chinese.
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Kidney; UBERON=UBERON_0002113.
ST   Source(s): CCRID=1101HUM-PUMC000598; PubMed=28256713
ST   Amelogenin: X,Y
ST   CSF1PO: 12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,13
ST   D19S433: 13,14.2
ST   D21S11: 30
ST   D2S1338: 20,24
ST   D3S1358: 17
ST   D5S818: 11,12
ST   D7S820: 11
ST   D8S1179: 11,12
ST   FGA: 23,26
ST   TH01: 6
ST   TPOX: 11
ST   vWA: 17,19
DI   NCIt; C4033; Clear cell renal cell carcinoma
DI   ORDO; Orphanet_319276; Clear cell renal carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   69Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-04-25; Version: 10
//
RX   PubMed=28256713; DOI=10.1002/ijc.30674;
RA   Feng H.-L., Zhang Y., Liu K., Zhu Y., Yang Z.-L., Zhang X., Liu Y.-Q.;
RT   "Intrinsic gene changes determine the successful establishment of
RT   stable renal cancer cell lines from tumor tissue.";
RL   Int. J. Cancer 140:2526-2534(2017).
//